𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study

✍ Scribed by John Fitzpatrick

Book ID
118440408
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
164 KB
Volume
5
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 3 randomized controlled trial of
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
✍ Michael A. Carducci; Fred Saad; Per-Anders Abrahamsson; David P. Dearnaley; Clau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin‐A receptor antagonist, in patients with metastatic hormone‐refractory prostate cancer (HRPC). ## METHODS. This multinational, double‐blind, placebo‐contro